We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
NOX.AU

Price
0.07
Stock movement down
-0.01 (-11.39%)
Company name
Noxopharm Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
20.46M
Ent value
19.43M
Price/Sales
4.04
Price/Book
3.72
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-31.55%
1 year return
11.11%
3 year return
-40.95%
5 year return
-18.53%
10 year return
-
Last updated: 2025-04-05

DIVIDENDS

NOX.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales4.04
Price to Book3.72
EV to Sales3.84

FINANCIALS

Per share

Per share data
Current share count292.24M
EPS (TTM)-0.05
FCF per share (TTM)-0.04

Income statement

Income statement data
Revenue (TTM)5.06M
Gross profit (TTM)3.57M
Operating income (TTM)-14.92M
Net income (TTM)-13.21M
EPS (TTM)-0.05
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)70.46%
Operating margin (TTM)-294.66%
Profit margin (TTM)-260.78%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash2.32M
Net receivables2.40M
Total current assets4.77M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment5.67K
Total assets6.78M
Accounts payable649.45K
Short/Current long term debt0.00
Total current liabilities1.25M
Total liabilities1.29M
Shareholder's equity5.50M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-13.05M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-13.05M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-240.35%
Return on Assets-194.70%
Return on Invested Capital-240.35%
Cash Return on Invested Capital-237.46%

STOCK INFORMATION

Stock chart

Stock price data
Open0.07
Daily high0.07
Daily low0.07
Daily Volume95K
All-time high1.58
1y analyst estimate1.00
Beta0.69
EPS (TTM)-0.05
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
NOX.AUS&P500
Current price drop from All-time high-95.57%-17.56%
Highest price drop-97.85%-56.47%
Date of highest drop13 Sep 20239 Mar 2009
Avg drop from high-70.35%-11.07%
Avg time to new high103 days12 days
Max time to new high1829 days1805 days
COMPANY DETAILS
NOX.AU (Noxopharm Ltd) company logo
Marketcap
20.46M
Marketcap category
Small-cap
Description
Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia. It develops Sofra, a platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatment of autoimmune diseases; and Chroma technology platform to develop CRO-67 dual-cell therapy drug for the treatment of pancreatic cancer and various molecules for the treatment of autoimmune disease and hyperinflammatory conditions. The company also develops orphan drug designations to treat less common disease; and IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of various solid tumor types. Noxopharm Limited was incorporated in 2015 and is based in Glenhaven, Australia.
Employees
0
Website
https://www.noxopharm.com
Investor relations
-
SEC filings
NOX.AU SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved